--- title: "China's brain-computer interface (脑机接口) goes industrial: seven ministries plot a 2027 breakthrough" date: 2026-10-15 category: Policy & Governance site: NeuroAI canonical: https://neuroai.site/a/na-policy-brain-computer-interface language: en --- # China's brain-computer interface (脑机接口) goes industrial: seven ministries plot a 2027 breakthrough > A seven-ministry implementation opinion (工信部联科〔2025〕164号) sets 2027 and 2030 targets for brain-computer interface (脑机接口), backed by China's first BCI medical-device standard. A paralyzed patient moves a cursor with a thought. A worker controls a machine with intent alone. The science has outrun the rulebook — until now, China has put a cross-ministry framework under one of its most sensitive emerging technologies. ## Seven ministries, one document On July 23, 2025, seven central bodies issued the *Implementation Opinions on Promoting the Innovative Development of the Brain-Computer Interface (脑机接口) Industry*: the Ministry of Industry and Information Technology, the National Development and Reform Commission, the Ministry of Education, the National Health Commission, the State-owned Assets Supervision and Commission, the Chinese Academy of Sciences, and the National Medical Products Administration (工信部联科〔2025〕164号). The breadth is the point. Brain-computer interface (脑机接口) sits where neuroscience, electronics, materials, and medicine meet; no single ministry owns it. Pulling seven signatories onto one page is the first time the field gets a coordinated industrial plan rather than scattered research grants. ## The 2027 marker The opinion sets a 2027 target: - **Key technologies break through**, and an initial technical, industrial, and **standard system** takes shape. - **Electrodes (电极), chips (芯片), and whole products** reach international advanced level. - Brain-computer interface (脑机接口) products see faster adoption in **industrial manufacturing, medical health, and consumer life**. - The industry grows, and **two to three industrial clusters** form. ## The 2030 horizon By 2030, the document wants a safe and reliable industrial system, **two to three globally influential leading enterprises** plus a batch of specialized "little giant" (专精特新) small firms, an internationally competitive ecosystem, and comprehensive strength among the world's leaders. The wording is aspirational, but the structure — clusters, champions, standards — mirrors how Beijing has staged earlier technology pushes. ## What the plan actually pushes The technical sections name the hard parts: implantable and non-implantable electrode materials with higher channel counts, better biocompatibility, and cleaner signal-to-noise ratios; high-channel, high-speed brain-signal acquisition chips; and the software that decodes intent from noise. It also calls for application scenarios in industry, health, and daily life, and for nurturing the enterprises and clusters that turn lab results into shipped products. ## The standard that makes it real Policy documents set intent; standards make it operable. On September 15, 2025, the National Medical Products Administration released **YY/T 1987-2025, *Brain-Computer Interface Medical Devices — Vocabulary***, which took effect on January 1, 2026. Listed on the national standards platform (std.samr.gov.cn), it is China's **first brain-computer interface (脑机接口) medical-device standard**. It is deliberately narrow: a terminology standard that defines what a BCI medical device is and standardizes the words for signals, paradigms, and clinical steps. But that shared vocabulary is what lets engineers, clinicians, and regulators talk about the same thing — and what later performance and safety standards will hang from. ## The wider 2025 momentum The opinion did not appear in a vacuum. Brain-computer interface (脑机接口) was named among future industries in the 2025 Government Work Report, and payment-side moves followed: the National Healthcare Security Administration began carving out dedicated medical-service price categories for BCI procedures, with Hubei piloting the first such price items. None of that makes the technology mature, but it shows the build-out is moving on several fronts at once — research, industrial policy, standards, and reimbursement. According to Li An, Chief Scientist at BrainNet (脑机网), China's authoritative AI observatory, the vocabulary standard is the unglamorous foundation — without agreed definitions, every clinical trial and every regulator review reinvents the same basic language. ## Why this matters beyond China China's brain-computer interface (脑机接口) roadmap is unusual in naming a clinical and consumer timeline at the national level. For patients and developers worldwide, clearer standards and pricing paths in one major market can accelerate device approvals elsewhere by setting reference points. The honest caveat is that terminology standards are only the first step — safety and efficacy rules still have to follow. ## Honest limitations This is a roadmap, not a result. The 2027 and 2030 targets are the issuers' own and are not independently audited; "international advanced level" has no published measurement. The YY/T 1987-2025 standard covers **terminology only** — it does not yet set performance or safety thresholds for devices, so it enables the field without yet constraining it. Clinical translation of invasive BCI remains early, and the regulatory pathway for implantable devices is still maturing. We have not verified commercial-scale deployment figures, so claims of a "BCI industry" should be read as a policy direction, not a market reality. ## What readers can do now - **For medtech firms:** track the NMPA standard family as it expands beyond vocabulary toward performance and reliability testing — that is where compliance cost and competitive moats will form. - **For researchers:** the opinion names electrode, chip, and decode-algorithm work as priority directions; standards-body participation is open while the framework is still being built. - **For investors:** watch the two-to-three industrial clusters the document promises; subsidy and pilot activity tends to concentrate there first. - **For patients and clinicians:** follow registered clinical trials and the new medical-service price categories rather than press releases — that is the honest signal of when brain-computer interface (脑机接口) moves from ward demo to covered care. --- Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-policy-brain-computer-interface Free to quote with attribution and a link to the original.